Skip to main content
SpringerLink
Log in
Book cover

Blood Conservation in Cardiac Surgery pp 381–395Cite as

Pharmacologic Approaches to Coagulation (Aprotinin, Epsilon Amino Caproic Acid, DDAVP, Tranexamic Acid Therapy)

  • Chapter

Abstract

Bleeding and blood transfusion have long been associated risks of open-heart surgery. The source of this risk is twofold, being related both to the hemodilution and the coagulopathy that have to the present time been inherent components of cardiopulmonary bypass (CPB). The prevention and treatment of coagulopathy is the focus of this chapter.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Salzman EW, Weinstein MJ, Weintraub RM, et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery: a double-blind randomized trial. N Engl J Med 1986;314:140.

    Google Scholar 

  2. Royston D, Bidstrup BP, Taylor KM, Sapsford RN. Effect of aprotinin on need for blood transfusions after repeat open heart surgery.Lancet 1987;2:1289–1291.

    Article  PubMed  CAS  Google Scholar 

  3. Van Oeveren W, Jansen NJG, Bidstrup BP, et al. Effect of aprotinin on hemostatic mechanisms during cardiopulmonary bypass.Ann Thorac Surg 1987;44:640–645.

    Article  PubMed  Google Scholar 

  4. Tice DA, Reed GE, Clauss RH, Worth MH. Hemorrhage due to fibrinolysis occurring with open heart operations.J Thorac Cardiovasc Surg 1963;46:673–676.

    PubMed  CAS  Google Scholar 

  5. Mammen EF. Natural protease inhibitors in extracorporeal circulation.Ann NY Acad Sci 1968;146:754–762.

    Article  PubMed  CAS  Google Scholar 

  6. Ambrus JL, Schimert G, Lajos TZ, et al. Effects of antifibrinolytic agents and estrogens on blood loss and blood coagulation factors during open heart surgery. J Med 1971;2:65–81.

    Article  PubMed  CAS  Google Scholar 

  7. Fritz H, Wunderer G. Biochemistry and application of aprotinin, the kallikrein inhibitor from bovine lungs. Arzneimittelforschung 1983;33:479–494.

    PubMed  CAS  Google Scholar 

  8. Taylor KM. Effects of aprotinin on blood loss and blood use after cardiopulmonary bypass. In: Roque Pifarre, ed.Anticoagulation, Hemostasis, and Blood Preservation in Cardiovascular Surgery. Philadelphia: Hanley and Belfus, 1993.

    Google Scholar 

  9. Van Oeveren W, Harder HP, Roozendaal KJ, Eijsman L, Wildevuur CRH. Aprotinin protects platelets against the initial effects of cardiopulmonary bypass.J Thorac Cardiovasc Surg 1990;99:788–797.

    PubMed  Google Scholar 

  10. Dietrich W, Spannagl M, Jochum M, et al. Incidence of high dose aprotinin treatment on blood loss and coagulation patterns in patients undergoing myocardial revascularization.Anesthesiology 1990;73:1119–1126.

    Article  PubMed  CAS  Google Scholar 

  11. Bidstrup BP, Royston D, Sapsford RN, Taylor KM. Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol).J Thorac Cardiovasc Surg 1989;97:364–372.

    PubMed  CAS  Google Scholar 

  12. Wildevuur CRH, Eijsman L, Roozendaal KJ, Harder MP, Chang M, van Oeveren W. Platelet preservation during cardiopulmonary bypass with aprotinin.Eur J Cardiothorac Surg 1989;3:533–538.

    Article  PubMed  CAS  Google Scholar 

  13. O’Regan DJ, Giannopolous MD, Mediratta N, et al. Topical aprotinin in cardiac operations.Ann Thorac Surg 1994;58:778–782.

    Article  PubMed  Google Scholar 

  14. Adelman B, Michelson AD, Loscalzo J, Greenberg J, Handin RI. Plasmin effect on platelet glycoprotein Ib-von Willebrand factor interaction.Blood 1985;65:32–40.

    PubMed  CAS  Google Scholar 

  15. Hardy JF, Desroches J. Natural and synthetic antifibrinolytics in cardiac surgery.Can J Anaesth 1992;39:353–365.

    Article  PubMed  CAS  Google Scholar 

  16. deSmet A, Joen M, van Oeveren W, et al. Increased anticoagulation during cardiopulmonary bypass by aprotinin.J Thorac Cardiovasc Surg 1990;100:520–527.

    CAS  Google Scholar 

  17. Wang JS, Lin CY, Hung WT, Thisted RA, Karp RB. In vitro effects of aprotinin on activated clotting time measured with different activators.J Thorac Cardiovasc Surg 1992;104:1135–1140.

    PubMed  CAS  Google Scholar 

  18. Dietrich W, Jochum M. Effect of celite and kaolin on activated clotting time in the presence of aprotinin: activated clotting time is reduced by binding of aprotinin to kaolin.J Thorac Cardiovasc Surg 1995;109:177.

    Article  PubMed  CAS  Google Scholar 

  19. Cosgrove DM III, Heric B, Lytle BW, et al. Aprotinin therapy for reoperative myocardial revascularization: a placebo controlled trial.Ann Thorac Surg 1992;54:1031–1038.

    Article  PubMed  Google Scholar 

  20. Lemmer JH Jr, Stanford W, Bonney SL, et al. Aprotinin for coronary bypass operations: efficacy, safety, and influence on early saphenous vein graft patency.J Thorac Cardiovasc Surg 1994;107:543–553.

    PubMed  Google Scholar 

  21. Bidstrup BP, Underwood SR, Saprsford RN. Effect of aprotinin (trasylol) on aorto-coronary bypass graft patency.J Thorac Cardiovasc Surg 1993;105:147–153.

    PubMed  CAS  Google Scholar 

  22. Blauhut B, Gross C, Necek S, et al. Effect of high dose aprotinin on blood loss, platelet function, fibrinolysis, complement and renal function after cardiopulmonary bypass.J Thorac Cardiovasc Surg 1991;101:958–967.

    PubMed  CAS  Google Scholar 

  23. Lemmer JH, Stanford W, Bonney SL, et al. Aprotinin for coronary artery bypass grafting: effect on postoperative renal function.Ann Thorac Surg 1995;59:132–136.

    Article  PubMed  Google Scholar 

  24. Verstraete M. Clinical application of inhibitors of fibrinolysis.Drugs 1985;29:236–261.

    Article  PubMed  CAS  Google Scholar 

  25. Ogston D. Current status of antifibrinolytic drugs.Blood Rev 1989;3:1–4.

    Article  PubMed  CAS  Google Scholar 

  26. Marin HM. Hemostatic mechanism in extracorporeal circulation.Arch Surg 1964;88:988–998.

    PubMed  CAS  Google Scholar 

  27. Horrow JC, Hlavacek J, Strong MD, et al. Prophylactic tranexamic acid decreases bleeding after cardiac operations.J Thorac Cardiovasc Surg 1990;99:70–74.

    PubMed  CAS  Google Scholar 

  28. Lambert CJ, Marengo-Rowe AJ, Levenson JE, et al. The treatment of postperfusion bleeding using ∈-aminocaproic acid, cryoprecipitate, fresh frozen plasma, and protamine sulfate.Ann Thorac Surg 1979;28:440–444.

    Article  PubMed  CAS  Google Scholar 

  29. VanderSalm TJ, Ansell JE, Okike ON, et al. The role of epsilon-aminocaproic acid in reducing bleeding after cardiac operations: a double blind, randomized study.J Thorac Cardiovasc Surg 1988;95:538–540.

    CAS  Google Scholar 

  30. Del Rossi AJ, Cernaianu AC, Botros S, Lemole GM, Moore R. Prophylactic treatment of postperfusion bleeding using EACA.Chest 1989;96:27–30.

    Article  Google Scholar 

  31. Sloand EM, Sloand J, Kessler C, et al. Loss of glycoprotein Ib from platelets on hemodialysis (HD) or cardiopulmonary bypass (CABG) is followed by its re-expression on the platelet membrane.Blood 1991;78:388a.

    Google Scholar 

  32. Sloand EM, Kessler CM, Sloand J, et al. DDAVP corrects the platelet dysfunction produced by cardiopulmonary bypass, hemodialysis, and prolonged storage: reexpression of glycoprotein lb on the platelet membrane. In Mariani G, Mannucci PM, Cattaneo M, eds.Desmopressin in Bleeding Disorders. London: Plenum, 1993.

    Google Scholar 

  33. Czer L, Bateman T, Gray RJ, et al. Prospective trial of DDAVP in treatment of severe platelet dysfunction and hemorrhage after cardiopulmonary bypass.Circulation 1995;72(Suppl 3):111.

    Google Scholar 

  34. Mariani G, Arcieri P, Pizzo F. The use of desmopressin in cardiopulmonary bypass surgery. In: Roque Pifarre, ed.Anticoagulation, Hemostasis, and Blood Preservation in Cardiovascular Surgery. Philadelphia: Hanley and Belfus, 1993.

    Google Scholar 

  35. Monogan PD, Hosking MP. The role of desmopressin acetate in patients undergoing coronary artery bypass surgery.Anesthesiology 1992;77:38–46.

    Article  Google Scholar 

  36. Salzman EW, Weinstein MJ, Reilly D, Ware A. Adventures in hemostasis: desmopressin in cardiac surgery.Arch Surg 1993;128:212–217.

    PubMed  CAS  Google Scholar 

  37. Fremes SE, Wong BI, Lee E, et al. Metaanalysis of prophylactic drug treatment in the prevention of postoperative bleeding.Ann Thorac Surg 1994;58:1580–1588.

    Article  PubMed  CAS  Google Scholar 

  38. Blauhut B, Harringer W, Bettelheim P, et al. Comparison of the effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass.J Thorac Cardiovasc Surg 1994;108:1083–1091.

    PubMed  CAS  Google Scholar 

  39. Speekenbrink RGH, Vonk ABA, Wildevuur CRH, Eijsman L. Hemostatic efficacy of dipyrimidole, tranexamic acid, and aprotinin in coronary bypass grafting.Ann Thorac Surg 1995;59:438–442.

    Article  PubMed  CAS  Google Scholar 

  40. Karski JM, Teasdale SJ, Norman MD, et al. Prevention of postbypass bleeding with tranexamic acid and ∈-aminocaproic acid.J Cardiothorac Vase Anesth 1993;7:431–435.

    Article  CAS  Google Scholar 

  41. Taylor KM. Perioperative approaches to coagulation defects.Ann Thorac Surg 1993;56:S81.

    Article  Google Scholar 

  42. Pifarre R.Anticoagulation, Hemostasis, and Blood Preservation in Cardiovascular Surgery. Philadelphia: Hanley and Belfus, 1993.

    Google Scholar 

Download references

Authors
  1. Todd K. Rosengart
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Cardiothoracic Surgery, The New York Hospital-Cornell Medical Center, 10021, New York, NY, USA

    Karl H. Krieger M.D. (Professor and Vice Chairman) & O. Wayne Isom M.D. (Professor and Chairman) (Professor and Vice Chairman) &  (Professor and Chairman)

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

Rosengart, T.K. (1998). Pharmacologic Approaches to Coagulation (Aprotinin, Epsilon Amino Caproic Acid, DDAVP, Tranexamic Acid Therapy). In: Krieger, K.H., Isom, O.W. (eds) Blood Conservation in Cardiac Surgery. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-2180-7_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-2180-7_15

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-94908-6

  • Online ISBN: 978-1-4612-2180-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation